the Dutch-GERAF Study

Dijklander Ziekenhuis

Status: Active, not recruiting

Conditions: Atrial Fibrillation; Major Bleed; Frailty

Treatments: Device: HeartSDK

Study type: Observational

Funder types: Other

Identifiers

NCT05337202

WB 694

Details and patient eligibility

About

Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients.

This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.

Enrollment: 1,075 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

All newly referred patients of 65 years and older that visit geriatric outpatient services are eligible (including Fall clinic, Memory clinic, Pre-operative geriatric assessment clinic, or any other geriatric outpatient clinics that are led by a geriatrician).

Exclusion criteria

• The patient has a pacemaker or implantable cardioverter defibrillator.
• The patient is known with a severe dementia, MoCA ≤ 15 points.
• The patient has a severe tremor, from whatever cause, and thus is unable to use the PPG based smartphone AF detection algorithm.

Trial design